Hikma Launches New 503B Sterile Compounding Business
/PRNewswire/ -- Hikma Pharmaceuticals PLC ("Hikma"), the multinational pharmaceutical company, announces the launch of Hikma 503B – a new outsourced sterile...
Stay updated with breaking news from Us Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Hikma Pharmaceuticals PLC ("Hikma"), the multinational pharmaceutical company, announces the launch of Hikma 503B – a new outsourced sterile...
PLANEGG / MUNICH, GERMANY / ACCESSWIRE / Janauary 10, 2022 / MorphoSys AG (FSE:MOR; NASDAQ:MOR), announced today that Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys, will present at the 40
Facebook likes to present its fact-checkers as impartial arbiters of squeaky-clean truth. The reality, however, shows they are no more bound by the constraints of certainty and infallibility than the users they monitor. Mark Zuckerberg, the...
/PRNewswire/ -- Galderma announced today the new label for SCULPTRA® (injectable poly-L-lactic acid (PLLA)), the first and only FDA-approved PLLA facial...
/PRNewswire/ -- Gedeon Richter Plc. ("Richter") and Hikma Pharmaceuticals PLC ("Hikma") today announced that they have entered into an exclusive license...